Acunetx Inchttps://investorshangout.com/Acunetx-Inc-ANTX-58414/en-usThu, 24 Sep 2026 15:01:01 GMTCopyright InvestorsHangout.comwhytestocks: $ANTX News Article - ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts Fohttps://investorshangout.com/post/view?id=6670938https://investorshangout.com/post/view?id=6670938Tue, 13 Feb 2024 13:20:45 GMTwhytestocks: $ANTX News Article - AN2 Therapeutics Signs Grant Agreement to Discover Novel, Boron Based Therapieshttps://investorshangout.com/post/view?id=6622684https://investorshangout.com/post/view?id=6622684Tue, 26 Sep 2023 19:10:48 GMTwhytestocks: $ANTX News Article - AN2 Therapeutics to Present at Upcoming Investor Conferences https://investorshangout.com/post/view?id=6493207https://investorshangout.com/post/view?id=6493207Wed, 02 Nov 2022 20:20:48 GMTwhytestocks: $ANTX News Article - NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million https://investorshangout.com/post/view?id=6478226https://investorshangout.com/post/view?id=6478226Thu, 29 Sep 2022 14:05:48 GMTwhytestocks: $ANTX News Article - AN2 Therapeutics Reports Second Quarter 2022 Financial Results and Provides Bushttps://investorshangout.com/post/view?id=6452916https://investorshangout.com/post/view?id=6452916Thu, 11 Aug 2022 20:40:52 GMTwhytestocks: $ANTX News Article - AN2 Therapeutics Reports First Quarter 2022 Financial Results and Provides Busihttps://investorshangout.com/post/view?id=6400223https://investorshangout.com/post/view?id=6400223Tue, 10 May 2022 20:35:52 GMTwhytestocks: $ANTX News Article - AN2 Therapeutics Appoints Maggie FitzPatrick to Its Board of Directors https://investorshangout.com/post/view?id=6398959https://investorshangout.com/post/view?id=6398959Mon, 09 May 2022 12:30:49 GMT